Japan Approves World's First Viral Esophageal Cancer Drug

Japan just approved Telomelysin, the world's first virus-based treatment for esophageal cancer that uses modified cold viruses to attack tumors without the harsh side effects of chemotherapy.

This breakthrough offers hope to elderly patients who can't undergo surgery or conventional treatment.